Skip to main content

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

  1. EU-Startups55

    London's Unravel Health raises €2.96M for at-home hormone testing device

    London-based Unravel Health raised €2.96 million led by Conduit EIS Impact Fund and Wrightwood.

    Why it matters: The round shows how a saliva-based hormone reader is being funded toward early-access devices in 2027, with the same sensing technology already tested on other markers.

  1. Tech Funding News58

    Olympian Andrew Steele's Stride raises £4.6M for preventive health

    Stride, the preventive health membership founded by Olympic medalist Andrew Steele.

    Why it matters: Stride's seed round shows how consumer preventive health is being built around lab diagnostics and an AI copilot, with retention as the open question.

  2. AlleyWatch Funding65

    Allara raises $30M to expand AI-backed women's hormonal care

    Allara raised a $30M round, bringing total funding to $75M, with existing investors Index Ventures and GV increasing their commitments and Camino Partners.

    Why it matters: Allara's $30M round and its plan to push AI from intake through treatment show how an insurance-covered virtual clinic intends to scale specialty care.

  1. Tech Funding News71

    Scarlet raises $50M Series B led by Headline to certify AI medical devices

    Scarlet, founded by ex-Babylon Health medical AI engineers, raised a $50M Series B led by Headline.

    Why it matters: Scarlet's $50M round shows how AI medical device certification is becoming its own business, with named customers and a regulatory bottleneck spelled out.

  1. AlleyWatch Funding65

    Polyphron Raises $20M Seed Led by Quiet Capital to Predict Drug Toxicity in Human Tissue

    Polyphron raised $20M in seed funding led by Quiet Capital, with Haystack, Gradient and Compound participating. The New York company grows donor-defined human tissue in an automated lab.

    Why it matters: The interview details how Polyphron pairs lab-grown human tissue with longitudinal data to train predictive models, a concrete look at the tissue-as-verification layer for drug testing.

  1. AlleyWatch Funding71

    Wally Raises $25M Series A to Expand Flat-Fee Dental Membership

    Wally raised a $25M Series A led by Maveron, with Bling Capital and angel investors including Hims cofounder Jack Abraham.

    Why it matters: Wally's flat-fee dental membership and AI-run clinics show how subscription pricing can realign incentives in a fragmented, insurance-driven market.

You’ve reached the end

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing